A Case Series of 13 Patients with COVID-19 Associated Respiratory Symptoms Treated with Nebulized OTR4120 (Cacipliq20®). acmcr [Internet]. 2022 Aug. 26 [cited 2026 Sep. 11];6(4):604-10. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22658